|
|
|
Volumn 2, Issue 2, 2000, Pages 290-291
|
|
Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
CHROMAN DERIVATIVE;
PIOGLITAZONE;
THIAZOLE DERIVATIVE;
TROGLITAZONE;
ARTICLE;
CLINICAL TRIAL;
DRUG INDUSTRY;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
SAFETY;
UNITED STATES;
CHROMANS;
CLINICAL TRIALS;
CONSUMER PRODUCT SAFETY;
DIABETES MELLITUS, TYPE 2;
DRUG INDUSTRY;
HUMANS;
HYPOGLYCEMIC AGENTS;
THIAZOLES;
THIAZOLIDINEDIONES;
UNITED STATES;
|
|
EID: 0034208987
PISSN: 15209156
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|